A detailed history of Paradigm Capital Management Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 300,000 shares of ETON stock, worth $3.74 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
300,000
Previous 300,000 -0.0%
Holding current value
$3.74 Million
Previous $987,000 82.37%
% of portfolio
0.08%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$2.02 - $3.25 $606,000 - $975,000
300,000 New
300,000 $846,000
Q3 2022

Oct 26, 2022

BUY
$2.04 - $3.03 $204,000 - $303,000
100,000 Added 50.0%
300,000 $630,000
Q2 2022

Aug 02, 2022

BUY
$2.55 - $4.38 $254,999 - $438,000
100,000 Added 100.0%
200,000 $524,000
Q1 2022

May 25, 2022

BUY
$3.43 - $4.69 $34,300 - $46,900
10,000 Added 11.11%
100,000 $436,000
Q4 2021

Feb 09, 2022

BUY
$3.66 - $6.59 $329,400 - $593,100
90,000 New
90,000 $386,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $315M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.